MPR Weekly Dose 146 — Paxlovid, Lagevrio EUA Revised; Beta Blockers and Violence; Jesduvroq Approved; Artificial Tears Product Recall; FDA Halt Use of COVID Therapy

This week: New adjunct treatment for Parkinson disease; Pain med associated with hypoglycemia; New approval for active ankylosing spondylitis; Fast track designation for possible kidney disease therap...

30 Elo 20196min

This week: New draft guidelines for Lyme Disease management; First-in-class antibiotic to treat community-acquired bacterial pneumonia; Duchenne muscular dystrophy drug denied; Approval for a rheumato...

23 Elo 20195min

This week the team discuss the 'Cure All' treatments that contain bleach, news concerning a Parkinson disease treatment, a new approval for a tuberculosis treatment, differences between the US and Can...

19 Elo 20197min